C-265 , 45th Parliament, 1st session Monday, May 26, 2025, to present
An Act to amend the Food and Drugs Act (List of Therapeutic Products Pre-approved for Special Access)
Summary
Current status
At consideration in committee in the House of Commons
Latest activity
Second reading and referral to committee on Wednesday, June 10, 2026 (House of Commons)
Progress
House of Commons
End of stage activity
Introduction and first reading, Wednesday, March 11, 2026
Chamber sittings
| Sitting date | Debates (Hansard) |
|---|---|
Wednesday, March 11, 2026 |
End of stage activity
Second reading and referral to committee, Wednesday, June 10, 2026
Placed on the order of precedence on Thursday, March 19, 2026
Chamber sittings
| Sitting date | Debates (Hansard) |
|---|---|
Friday, May 8, 2026 |
|
Wednesday, June 10, 2026 |
Sitting 133
Agreed to
(Journals 133)
|
Consideration in committee
No activity
Report stage
Not reached
Third reading
Not reached
First reading
Not reached
Second reading
Not reached
Third reading
Not reached
Details
Recorded votes
House of Commons
There are currently no recorded votes for this bill.
Senate
To view the complete list of standing votes that have taken place in the Senate, please refer to the Votes page of the Senate of Canada website.Speaker's rulings and statements
There are currently no Speaker's rulings and statements.
Major speeches at second reading
House of Commons
| Speech date | Speech | Member of Parliament |
|---|---|---|
| Friday, May 8, 2026 | Sponsor’s speech(Sitting 120) | Marcus Powlowski (Liberal) |
| Friday, May 8, 2026 | Response speech(Sitting 120) | Burton Bailey (Conservative) |
| Friday, May 8, 2026 | Response speech(Sitting 120) | Mario Simard (Bloc Québécois) |
About
Similar bills
No similar bills were introduced during previous sessions or Parliaments
From the Library of Parliament
The Library of Parliament’s research publications provide non-partisan, reliable and timely information and analysis on current and emerging issues, legislation and major public policy topics.